Development of a Murine Infection Model with<i> Leishmania killicki</i>, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology

<div>Clinical evolution of the ear lesions in BALB/c mice. Lesions’ appearance in mice infected with<i> L. major </i>(4th week after infection) (a) or<i> L. killicki</i> (20th week after infection) (b).</div>

BioMed Research International

fig1

Figure 1

Figure 1: Development of a Murine Infection Model with<i> Leishmania killicki</i>, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology 

Figure 1 | Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology 